107 related articles for article (PubMed ID: 17456993)
1. Plasma level of mitochondrial coupling factor 6 increases in patients with coronary heart disease.
Chai SB; Hui YM; Li XM; Tang CS
Circ J; 2007 May; 71(5):693-7. PubMed ID: 17456993
[TBL] [Abstract][Full Text] [Related]
2. Plasma level of mitochondrial coupling factor 6 increases in patients with type 2 diabetes mellitus.
Li XL; Xing QC; Dong B; Gao YY; Xing SS; Pang YZ; Jiang HF; Tang CS
Int J Cardiol; 2007 May; 117(3):411-2. PubMed ID: 16899312
[TBL] [Abstract][Full Text] [Related]
3. Plasma concentration of coupling factor 6 and cardiovascular events in patients with end-stage renal disease.
Osanai T; Nakamura M; Sasaki S; Tomita H; Saitoh M; Osawa H; Yamabe H; Murakami S; Magota K; Okumura K
Kidney Int; 2003 Dec; 64(6):2291-7. PubMed ID: 14633154
[TBL] [Abstract][Full Text] [Related]
4. Plasma mitochondrial coupling factor 6 in patients with acute myocardial infarction.
Ding WH; Chu SY; Jiang HF; Cai DY; Pang YZ; Tang CS; Qi YF
Hypertens Res; 2004 Oct; 27(10):717-22. PubMed ID: 15785006
[TBL] [Abstract][Full Text] [Related]
5. Coupling Factor 6 Is Upregulated in Monocrotaline-induced Pulmonary Arterial Hypertension in Rats.
Li N; Yin J; Cai W; Liu J; Zhang N; Yan S; Song L; Li X
Am J Med Sci; 2016 Dec; 352(6):631-636. PubMed ID: 27916219
[TBL] [Abstract][Full Text] [Related]
6. Lung-specific RNA interference of coupling factor 6, a novel peptide, attenuates pulmonary arterial hypertension in rats.
Yin J; You S; Li N; Jiao S; Hu H; Xue M; Wang Y; Cheng W; Liu J; Xu M; Yan S; Li X
Respir Res; 2016 Aug; 17(1):99. PubMed ID: 27491388
[TBL] [Abstract][Full Text] [Related]
7. Mitochondrial coupling factor 6 is present on the surface of human vascular endothelial cells and is released by shear stress.
Osanai T; Okada S; Sirato K; Nakano T; Saitoh M; Magota K; Okumura K
Circulation; 2001 Dec; 104(25):3132-6. PubMed ID: 11748113
[TBL] [Abstract][Full Text] [Related]
8. Tumor necrosis factor alpha as an endogenous stimulator for circulating coupling factor 6.
Sasaki S; Osanai T; Tomita H; Matsunaga T; Magota K; Okumura K
Cardiovasc Res; 2004 Jun; 62(3):578-86. PubMed ID: 15158150
[TBL] [Abstract][Full Text] [Related]
9. Novel pro-atherogenic molecule coupling factor 6 is elevated in patients with stroke: a possible linkage to homocysteine.
Osanai T; Fujiwara N; Sasaki S; Metoki N; Saitoh G; Tomita H; Nishimura T; Shibutani S; Yokoyama H; Konta Y; Magota K; Okumura K
Ann Med; 2010; 42(1):79-86. PubMed ID: 20092401
[TBL] [Abstract][Full Text] [Related]
10. Troglitazone and 15-deoxy-delta(12,14)-prostaglandin J2 inhibit shear-induced coupling factor 6 release in endothelial cells.
Tomita H; Osanai T; Toki T; Sasaki S; Maeda N; Murakami R; Magota K; Yasujima M; Okumura K
Cardiovasc Res; 2005 Jul; 67(1):134-41. PubMed ID: 15949477
[TBL] [Abstract][Full Text] [Related]
11. Coupling factor 6-induced prostacyclin inhibition is enhanced in vascular smooth muscle cells from spontaneously hypertensive rats.
Osanai T; Tomita H; Yamada M; Tanaka M; Ashitate T; Echizen T; Katoh C; Magota K; Okumura K
J Hypertens; 2009 Sep; 27(9):1823-8. PubMed ID: 19474762
[TBL] [Abstract][Full Text] [Related]
12. Mitochondrial Inhibitory Factor Protein 1 Functions as an Endogenous Inhibitor for Coupling Factor 6.
Kawai M; Osanai T; Tanaka M; Magota K; Tomita H; Okumura K
J Cell Biochem; 2016 Jul; 117(7):1680-7. PubMed ID: 26659871
[TBL] [Abstract][Full Text] [Related]
13. Nutritional regulation of coupling factor 6, a novel vasoactive and proatherogenic peptide.
Osanai T; Mikami K; Kitajima M; Urushizaka M; Kawasaki K; Tomisawa T; Itaki C; Noto Y; Magota K; Tomita H
Nutrition; 2017 May; 37():74-78. PubMed ID: 28359367
[TBL] [Abstract][Full Text] [Related]
14. Coupling factor 6 as a novel vasoactive and proatherogenic peptide in vascular endothelial cells.
Osanai T; Magota K; Okumura K
Naunyn Schmiedebergs Arch Pharmacol; 2009 Sep; 380(3):205-14. PubMed ID: 19488738
[TBL] [Abstract][Full Text] [Related]
15. Coupling factor 6 enhances Src-mediated responsiveness to angiotensin II in resistance arterioles and cells.
Osanai T; Tomita H; Kushibiki M; Yamada M; Tanaka M; Ashitate T; Echizen T; Katoh C; Magota K; Okumura K
Cardiovasc Res; 2009 Mar; 81(4):780-7. PubMed ID: 19106112
[TBL] [Abstract][Full Text] [Related]
16. Upregulation of soluble vascular endothelial growth factor receptor type 1 by endogenous prostacyclin inhibitor coupling factor 6 in vascular endothelial cells: a role of acidosis-induced c-Src activation.
Echizen T; Osanai T; Ashitate T; Yokoyama H; Shibutani S; Tanaka M; Tomita H; Magota K; Okumura K
Hypertens Res; 2009 Mar; 32(3):182-7. PubMed ID: 19262480
[TBL] [Abstract][Full Text] [Related]
17. Coupling factor 6 enhances the spontaneous microaggregation of platelets by decreasing cytosolic cAMP irrespective of antiplatelet therapy.
Sukekawa T; Osanai T; Nishizaki F; Metoki N; Hagii J; Kamada T; Yasujima M; Tomita H; Magota K; Okumura K
Hypertens Res; 2013 Jun; 36(6):520-7. PubMed ID: 23388886
[TBL] [Abstract][Full Text] [Related]
18. Mitochondrial inhibitory factor protein 1 attenuates coupling factor 6-induced aging signal.
Osanai T; Tanaka M; Mikami K; Kitajima M; Magota K; Tomita H; Okumura K
J Cell Biochem; 2018 Jul; 119(7):6194-6203. PubMed ID: 29575130
[TBL] [Abstract][Full Text] [Related]
19. Intracellular signaling for vasoconstrictor coupling factor 6: novel function of beta-subunit of ATP synthase as receptor.
Osanai T; Magota K; Tanaka M; Shimada M; Murakami R; Sasaki S; Tomita H; Maeda N; Okumura K
Hypertension; 2005 Nov; 46(5):1140-6. PubMed ID: 16230521
[TBL] [Abstract][Full Text] [Related]
20. Increased plasma levels of endothelin-1 and urotensin-II in patients with coronary heart disease.
Chai SB; Li XM; Pang YZ; Qi YF; Tang CS
Heart Vessels; 2010 Mar; 25(2):138-43. PubMed ID: 20339975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
